BENEFIX
As listed in the register: BENEFIX
3000 unit · powder for solution
- Prescription status not stated
- Blood, clotting and anaemia
- Active substance
- Coagulation Factor Ix (Recombinant)
- Used in
- Blood, clotting and anaemia
- Made by
- Pfizer Canada Ulc
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
How it works
From the US prescribing label for the same active substance (Ixinity). It describes the substance, not this exact product.
Hemophilia B is a sex-linked hereditary disorder of blood coagulation caused by a deficiency in factor IX and results in bleeding into joints, muscles or internal organs, either spontaneously or as a result of accidental or surgical trauma.
Treatment with IXINITY replaces factor IX, thereby enabling a temporary correction of the factor deficiency and correction of the bleeding tendencies.
Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2024-04-03
Safety of the active substance
From the US prescribing label for the same active substance (Ixinity). It describes the substance, not this exact product.
- IXINITY is contraindicated in patients who have known hypersensitivity to IXINITY or its excipients, including hamster protein [see Warnings and Precautions (5.1) ].
- Do not use in patients with known hypersensitivity to IXINITY or its excipients, including hamster protein ( 4 )
The most common adverse reaction (> 2%) reported in clinical trials was headache.
Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
United StatesNo exact match for this strength and form
European UnionNo exact match for this strength and form
SpainNo exact match for this strength and form
NetherlandsNo exact match for this strength and form
SwitzerlandNo exact match for this strength and form
Details
| Made by | Pfizer Canada Ulc |
|---|---|
| Active substance | Coagulation Factor Ix (Recombinant) |
| Used in | Blood, clotting and anaemia |
| Strength | 3000 unit |
| Form | powder for solution |
| Classification | B02BD04 · Blood, clotting and anaemia |
| Route | intravenous |
| Dispensing (as stated by the register) | SCHEDULE D |
| Status | Marketed |
| Marketed | Yes, according to the register |
| DIN | 02392984 |
| DPD drug code | 87824 |
Source: Drug Product Database · 2026-09-30 · not reviewed by a clinician
Contains information licensed under the Open Government Licence – Canada. Reuse terms: Open Government Licence – Canada.
Other strengths and forms
6 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.